| Literature DB >> 24050280 |
María Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli.
Abstract
Allosteric modulators of adenosine receptors represent an alternative to direct-acting adenosine agonists and nucleoside uptake blockers, preferably those can selectively modulate the response to adenosine in only those organs or localized areas of a given organ in which production of adenosine is increased. Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, this class of compounds has therapeutic potential as analgesics and neuroprotective agents.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24050280 DOI: 10.1016/j.ddtec.2012.08.005
Source DB: PubMed Journal: Drug Discov Today Technol ISSN: 1740-6749